Your search returned 8 results.

Results
	1.	Repression by SSN6-TUP1 is directed by MIG1, a repressor/activator protein. [electronic resource] by Treitel, M A Carlson, M Producer: 19950525 In: Proceedings of the National Academy of Sciences of the United States of America vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Snf1 protein kinase regulates phosphorylation of the Mig1 repressor in Saccharomyces cerevisiae. [electronic resource] by Treitel, M A Kuchin, S Carlson, M Producer: 19981123 In: Molecular and cellular biology vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The SNF5 protein of Saccharomyces cerevisiae is a glutamine- and proline-rich transcriptional activator that affects expression of a broad spectrum of genes. [electronic resource] by Laurent, B C Treitel, M A Carlson, M Producer: 19901205 In: Molecular and cellular biology vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Functional interdependence of the yeast SNF2, SNF5, and SNF6 proteins in transcriptional activation. [electronic resource] by Laurent, B C Treitel, M A Carlson, M Producer: 19910506 In: Proceedings of the National Academy of Sciences of the United States of America vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	N-terminal mutations modulate yeast SNF1 protein kinase function. [electronic resource] by Estruch, F Treitel, M A Yang, X Carlson, M Producer: 19930128 In: Genetics vol. 132 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up. [electronic resource] by Hotho, D M de Bruijne, J Spaan, M Treitel, M A Boonstra, A de Knegt, R J Janssen, H L A Reesink, H W Producer: 20130828 In: Journal of viral hepatitis vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1. [electronic resource] by Tatum, H Thuluvath, P J Lawitz, E Martorell, C DeMicco, M Cohen, S Rustgi, V Ravendhran, N Ghalib, R Hanson, J Zamparo, J Zhao, J Cooney, E Treitel, M Hughes, E Producer: 20160322 In: Journal of viral hepatitis vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitor. [electronic resource] by de Bruijne, J Thomas, X V Rebers, S P Weegink, C J Treitel, M A Hughes, E Bergmann, J F de Knegt, R J Janssen, H L A Reesink, H W Molenkamp, R Schinkel, J Producer: 20140602 In: Journal of viral hepatitis vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)